Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Oct 1, 2021
Distillery Therapeutics

Inhibiting ICAM-1 to block breast cancer lung metastases

BioCentury | Jul 19, 2018
Translation in Brief

Inflammatory images

How inflammasome activation mediates contrast agent-induced acute kidney injury
BioCentury | Mar 22, 2016
Financial News

Atlantic raises $24M venture round

BioCentury | Feb 15, 2016
Clinical News

Alicaforsen: Phase III started

BioCentury | May 31, 2010
Clinical News

Alicaforsen regulatory update

BioCentury | Feb 15, 2010
Finance

Mipomersen chronicles

BioCentury | Apr 20, 2009
Clinical News

Alicaforsen regulatory update

Items per page:
1 - 10 of 54